OMER · NASDAQ
Omeros (OMER) Stock Price & Fundamentals
Omeros (OMER) closed at $489.94 on Oct 9, 2026, up 1.02% from the previous close of $484.97.
Share price, past year
1Y +0.26%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $489.94 |
| Sep 30, 2026 | $495.08 |
| Aug 31, 2026 | $536.01 |
| Jul 31, 2026 | $523.99 |
| Jun 30, 2026 | $558.09 |
| May 29, 2026 | $561.03 |
| Apr 30, 2026 | $547.58 |
| Mar 31, 2026 | $554.44 |
| Feb 27, 2026 | $520.40 |
| Jan 30, 2026 | $512.21 |
| Dec 31, 2025 | $569.37 |
| Nov 28, 2025 | $493.15 |
| Oct 31, 2025 | $485.12 |
Key statistics
- Market cap
- $35.32B
- P/E (TTM)
- 283.2
- EPS (TTM)
- $1.73
- Revenue (TTM)
- —
- Net income (TTM)
- $124.83M
- Shares outstanding
- 72.1M
- Dividend yield
- —
- 52-week range
- $479.37 – $580.14
Omeros's market cap is $35.32B, based on a share price of $489.94 and 72.1M shares outstanding as of Jun 30, 2026.
Financials
Omeros reported revenue of $73.81M for fiscal 2020, down 33.98% from fiscal 2019.
Omeros reported a net loss of $3.35M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $73.81M | −34.0% | −$138.06M | −187.0% | −$2.41 | −$100.37M |
| FY2019ended Dec 31, 2019 | $111.81M | +274.3% | −$84.49M | −75.6% | −$1.71 | −$60.41M |
| FY2018ended Dec 31, 2018 | $29.87M | −53.9% | −$126.76M | −424.4% | −$2.61 | −$104.30M |
| FY2017ended Dec 31, 2017 | $64.83M | +55.8% | −$53.48M | −82.5% | −$1.17 | −$36.58M |
| FY2016ended Dec 31, 2016 | $41.62M | +208.1% | −$66.75M | −160.4% | −$1.65 | −$51.63M |
| FY2015ended Dec 31, 2015 | $13.51M | +2,406.3% | — | — | — | — |
| FY2014ended Dec 31, 2014 | $539.00K | −66.3% | — | — | — | — |
| FY2013ended Dec 31, 2013 | $1.60M | −73.4% | — | — | — | — |
| FY2012ended Dec 31, 2012 | $6.02M | +33.1% | — | — | — | — |
| FY2011ended Dec 31, 2011 | $4.52M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $28.53M | $13.23M | $0.15 |
| Q1 FY2026ended Mar 31, 2026 | $9.89M | $56.06M | $0.62 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$25.42M | −$0.43 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$33.46M | −$0.58 |
| Q3 FY2021ended Sep 30, 2021 | $30.00M | — | — |
| Q2 FY2021ended Jun 30, 2021 | $28.82M | — | — |
| Q1 FY2021ended Mar 31, 2021 | $21.06M | — | — |
| Q4 FY2020ended Dec 31, 2020 | $10.63M | — | — |
Company profile
- Name
- Omeros Corporation
- Ticker
- OMER
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 201 Elliott Avenue West, Seattle, WA 98119
- Incorporated in
- WA
- Fiscal year ends
- December
- SEC CIK
- 0001285819
Recent SEC filings
- Aug 13, 2026
- Aug 12, 2026
- Aug 12, 2026
- Jul 20, 2026
- Jul 6, 2026
- Jun 25, 2026
- Jun 18, 2026
- May 13, 2026
Frequently asked questions
What is Omeros's stock price?
Omeros (OMER) closed at $489.94 on Oct 9, 2026, up 1.02% from the previous close of $484.97.
What is Omeros's market cap?
Omeros's market cap is $35.32B, based on a share price of $489.94 and 72.1M shares outstanding as of Jun 30, 2026.
How much revenue does Omeros make?
Omeros reported revenue of $73.81M for fiscal 2020, down 33.98% from fiscal 2019.
What is OMER's P/E ratio?
Omeros's price-to-earnings ratio is 283.2, based on trailing twelve-month diluted EPS of $1.73.
Does Omeros pay a dividend?
Omeros's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Omeros Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures